551001-56-0

Basic information

• Product Name: [2-(3-Fluoro-4-methoxy-phenyl)-5-methoxy-benzofuran-7-yl]-methanol
• CAS NO: 551001-56-0
• Molecular Weight: 302.302
• Mol File: 551001-56-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [2-(3-Fluoro-4-methoxy-phenyl)-5-methoxy-benzofuran-7-yl]-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(3-Fluoro-4-methoxy-phenyl)-5-methoxy-benzofuran-7-yl]-methanol(551001-56-0)
• EPA Substance Registry System: [2-(3-Fluoro-4-methoxy-phenyl)-5-methoxy-benzofuran-7-yl]-methanol(551001-56-0)

Safety Data

• Hazardous Substances Data: 551001-56-0(Hazardous Substances Data)

Upstream product

• 2905-82-0 methyl 5-methoxy-2-hydroxybenzoate 
• 551002-38-1 methyl 3-iodo-5-methoxysalicylate 
• 16853-85-3 lithium aluminium tetrahydride 
• 551001-55-9 2-(3-Fluoro-4-methoxy-phenyl)-5-methoxy-benzofuran-7-carboxylic acid methyl ester 

Relevant articles and documents

PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION

The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.

Substituted 2-phenyl benzofurans as estrogenic agents

This invention provides estrogen receptor modulators of formula I, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.